Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Clinical Evidence Current clinical evidence for both peptides remains notably limited in comparison to the extensive body of preclinical data
HPLC alone cannot confirm peptide identity mass spectrometry is required to verify that the measured compound is actually the target peptide and not a co-eluting impurity with similar retention characteristics
BPC-157 acts primarily through bidirectional modulation of the nitric oxide (NO) system, promoting angiogenesis and vasodilation
NuRev Peptides is unable to provide dosing, administration, or usage instructions
As of June 2026, AOD-9604 is listed as Nominated but Withdrawn , meaning it is no longer actively under Category 2 nomination
You can also visit Peptide Health Reviews for more information
